Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence

被引：6
作者：
Siegel, Abby B.
El-Serag, Hashem B.
机构：
[1] NY 10032, 622 West 168th Street, PH 14
来源：
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | 2013年 / 7卷 / 06期
关键词：
hepatocellular carcinoma; prevention; statin; HEPATITIS-C VIRUS; FATTY LIVER-DISEASE; METABOLIC SYNDROME; COLORECTAL-CANCER; UNITED-STATES; RISK-FACTOR; US ADULTS; METAANALYSIS; OBESITY; MORTALITY;
D O I：
10.1586/17474124.2013.814884
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：493 / 495
页数：3
相关论文
共 50 条
  • [31] Metabolic disorders across hepatocellular carcinoma in Italy
    Morisco, Filomena
    Guarino, Maria
    Valvano, Maria R.
    Auriemma, Francesco
    Farinati, Fabio
    Giannini, Edoardo G.
    Ciccarese, Francesca
    Tovoli, Francesco
    Rapaccini, Gian Ludovico
    Di Marco, Maria
    Caturelli, Eugenio
    Zoli, Marco
    Borzio, Franco
    Sacco, Rodolfo
    Cabibbo, Giuseppe
    Felder, Martina
    Benvengu, Luisa
    Gasbarrini, Antonio
    Baroni, Gianluca Svegliati
    Foschi, Francesco G.
    Biasini, Elisabetta
    Masotto, Alberto
    Virdone, Roberto
    Marra, Fabio
    Caporaso, Nicola
    Trevisani, Franco
    LIVER INTERNATIONAL, 2018, 38 (11) : 2028 - 2039
  • [32] Dietary Phytochemicals in the Chemoprevention and Treatment of Hepatocellular Carcinoma: In Vivo Evidence, Molecular Targets, and Clinical Relevance
    Bishayee, Anupam
    Thoppil, Roslin J.
    Waghray, Abhijeet
    Kruse, Jaclyn A.
    Novotny, Nicholas A.
    Darvesh, Altaf S.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (09) : 1191 - 1232
  • [33] Hepatocellular carcinoma surveillance: An evidence-based approach
    Harris, Patrick S.
    Hansen, Ross M.
    Gray, Meagan E.
    Massoud, Omar, I
    McGuire, Brendan M.
    Shoreibah, Mohamed G.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (13) : 1550 - 1559
  • [34] Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder
    Chiu, Wei-Che
    Shan, Jia-Chi
    Yang, Yao-Hsu
    Chen, Vincent Chin-Hung
    Chen, Pau-Chung
    DRUG AND ALCOHOL DEPENDENCE, 2021, 228
  • [35] An Ounce of Prevention Is Better Than a Pound of Cure: A Patient-Centered Approach to Hepatocellular Carcinoma
    Siegel, Abby B.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) : 1499 - 1501
  • [36] Chemoprevention - What is evidence based?
    Kolligs, F. T.
    Pox, C. P.
    ONKOLOGE, 2017, 23 (06): : 415 - 421
  • [37] Angiogenesis in Hepatocellular Carcinoma: A Potential Target for Chemoprevention and Therapy
    Bishayee, Anupam
    Darvesh, Altaf S.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (09) : 1095 - 1118
  • [38] Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro
    Chang, JS
    Chiang, LC
    Hsu, FF
    Lin, CC
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2004, 32 (05): : 717 - 725
  • [39] Statins in the elderly: What evidence of their benefit in prevention?
    Steg, Ph. Gabriel
    Tissot, Claire-Marie
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (02) : 61 - 65
  • [40] Management of Chronic Liver Disease in Patients with Hepatocellular Carcinoma
    Henry, Zachary H.
    Argo, Curtis K.
    CLINICS IN LIVER DISEASE, 2025, 29 (01) : 135 - 147
12345